REPLIGEN CORP — Director's Dealing 2022

Mar 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-03-08

Reporting Person: Snodgres Jon (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-08	Common Stock	M	2952	$33.87	Acquired	38685	Direct
2022-03-08	Common Stock	M	1214	$59.52	Acquired	39899	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-08	Stock Option (Right to Buy)	$33.87	M	2952	Acquired	2028-03-01	Common Stock (2952)	Direct
2022-03-08	Stock Option (Right to Buy)	$59.52	M	1214	Acquired	2029-02-28	Common Stock (1214)	Direct

Footnotes

F1: This option is currently exercisable.